InvestorsObserver
×
News Home

KITOV Pharma (KTOV) Stock Down -13.24%; Continues to Fall After Last Week's Spike from $35 Million Direct Offering

Wednesday, July 01, 2020 09:56 AM | Neal Farmer

Mentioned in this article

KITOV Pharma (KTOV) Stock Down -13.24%; Continues to Fall After Last Week's Spike from $35 Million Direct Offering

KITOV PHARMA LT/S ADR (KTOV) is down -13.24% today continuing its fall this week. The stock shot upwards last week when the company announced a $35 million registered direct offering. Two weeks ago the KTOV was trading around $0.47 until its reached highs of $1.39 last week off the news and market sentiment. The stock made news when Barstool Sports founder Dave Portnoy speculated on the stock and made huge profits off the short term gains.

KTOV stock has gained 1.05% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary scoring system, gives KTOV stock a score of 64 out of a possible 100.

That score is primarily influenced by a long-term technical score of 99. KTOV’s score also includes a short-term technical score of 93. The fundamental score for KTOV is 0.

What’s Happening with KTOV Stock Today

KITOV PHARMA LT/S ADR (KTOV) stock is lower by -13.24% while the S&P 500 has gained 0.46% as of 9:40 AM on Wednesday, Jul 1. KTOV is lower by -$0.15 from the previous closing price of $1.11 on volume of 8,652,278 shares. Over the past year the S&P 500 is up 4.76% while KTOV has gained 1.05%. KTOV lost -$0.07 per share in the over the last 12 months.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App